Reviva Pharmaceuticals I... (RVPHW)
undefined
undefined%
At close: undefined
0.31
-4.38%
After-hours Dec 13, 2024, 03:59 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Net Income -39.26M -24.34M -8.52M -3.78M -846.83K -1.68M
Depreciation & Amortization - - - 591.00 645.00 17.72K
Stock-Based Compensation 3.41M 176.74K 106.71K - - 21.05K
Other Working Capital 6.96M 2.00M -203.71K -3.10M 475.98K 541.98K
Other Non-Cash Items 239.22K 194.71K -1.55M 2.39M -6.41K 28.24K
Deferred Income Tax - - - - - -
Change in Working Capital 7.28M 5.01M -702.17K -2.33M 634.15K 541.98K
Operating Cash Flow -28.32M -18.96M -10.67M -3.73M -218.44K -1.07M
Capital Expenditures - - - - - -
Acquisitions - - - - - -
Purchase of Investments - - - - - -
Sales Maturities Of Investments - - - - - -
Other Investing Acitivies - - - - - -
Investing Cash Flow - - - - - -
Debt Repayment - - - - - -
Common Stock Repurchased - - - - - -
Dividend Paid - - - - - -
Other Financial Acitivies 5.68M 18.97K 98.48K 12.83M - 175.00K
Financial Cash Flow 33.17M 7.79M 31.60M 12.83M 100.00K 175.00K
Net Cash Flow 4.85M -11.17M 20.93M 8.76M -118.44K 118.64K
Free Cash Flow -28.32M -18.96M -10.67M -3.73M -218.44K -1.07M